Driehaus Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$266K Hold
38,977
– – ﹤0.01% 398
2026
Q2
$366K Buy
+38,977
New +$369K ﹤0.01% 350
2024
Q4
– Sell
-127,787
Closed -$2.64M – 401
2024
Q3
$2.64M Buy
127,787
+64,728
+103% +$3.31M 0.02% 294
2024
Q2
$2.85M Hold
63,059
– – 0.03% 281
2024
Q1
$2.47M Buy
+63,059
New +$1.55M 0.02% 297

Other funds holding CRBP

Driehaus Capital Management's CRBP Position: Q3 2026 in Review

Driehaus Capital Management held its Corbus Pharmaceuticals (CRBP) position steady in Q3 2026 at 38,977 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #398.

Driehaus Capital Management first reported a position in CRBP in Q1 2024 and has held it in 5 quarters since. The position peaked at $2.85M in Q2 2024. 120 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.

  • Driehaus Capital Management held 38,977 shares of Corbus Pharmaceuticals worth $266K as of Q3 2026.
  • Driehaus Capital Management left its Corbus Pharmaceuticals share count unchanged in Q3 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Driehaus Capital Management's portfolio in Q3 2026, its #398 holding.
  • Driehaus Capital Management first reported a position in Corbus Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • Driehaus Capital Management's Corbus Pharmaceuticals position peaked at $2.85M in Q2 2024.
  • 120 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.

Based on Driehaus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.